Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+3.97%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$29.2B
AUM Growth
+$2.25B
(+8.3%)
Cap. Flow
+$1.45B
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
43.25%
Holding
1,208
New
40
Increased
304
Reduced
790
Closed
71
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$714M |
| 2 |
Apple
AAPL
|
+$230M |
| 3 |
Texas Instruments
TXN
|
+$203M |
| 4 |
Advanced Micro Devices
AMD
|
+$174M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$161M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$251M |
| 2 |
NVIDIA
NVDA
|
+$119M |
| 3 |
Applied Materials
AMAT
|
+$92.6M |
| 4 |
Broadcom
AVGO
|
+$55.5M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$54.5M |
Sector Composition
| 1 | Technology | 45.19% |
| 2 | Financials | 9.32% |
| 3 | Healthcare | 4.8% |
| 4 | Consumer Discretionary | 4.12% |
| 5 | Industrials | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Applied Therapeutics
APLT
$64M
| $1.35M | ﹤0.01% |
+159,262
| New | +$1.35M |
|
727
Hexcel
HXL
$4.93B
| $1.35M | ﹤0.01% |
21,872
+164
| +0.8% | +$10.1K |
|
728
Perspective Therapeutics
CATX
$240M
| $1.35M | ﹤0.01% |
+101,138
| New | +$1.35M |
|
729
Sana Biotechnology
SANA
$739M
| $1.35M | ﹤0.01% |
324,531
-15,899
| -5% | -$66.1K |
|
730
Humacyte
HUMA
$234M
| $1.34M | ﹤0.01% |
246,999
+142,703
| +137% | +$776K |
|
731
Bath & Body Works
BBWI
$5.81B
| $1.32M | ﹤0.01% |
41,482
+12,845
| +45% | +$410K |
|
732
Enterprise Financial Services Corp
EFSC
$2.27B
| $1.32M | ﹤0.01% |
25,785
-11,481
| -31% | -$589K |
|
733
Tyson Foods
TSN
$19.7B
| $1.31M | ﹤0.01% |
22,063
-898
| -4% | -$53.5K |
|
734
Albemarle
ALB
$8.63B
| $1.31M | ﹤0.01% |
13,850
+711
| +5% | +$67.3K |
|
735
International Paper
IP
$24.5B
| $1.31M | ﹤0.01% |
26,813
-1,075
| -4% | -$52.5K |
|
736
City Holding Co
CHCO
$1.83B
| $1.31M | ﹤0.01% |
11,148
-6,580
| -37% | -$772K |
|
737
FB Financial Corp
FBK
$2.86B
| $1.31M | ﹤0.01% |
27,825
-10,318
| -27% | -$484K |
|
|
CDMO
738
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.3M | ﹤0.01% |
114,445
-69,861
| -38% | -$795K |
|
739
Vir Biotechnology
VIR
$713M
| $1.3M | ﹤0.01% |
173,852
+28,005
| +19% | +$210K |
|
740
AnaptysBio
ANAB
$637M
| $1.3M | ﹤0.01% |
38,698
-10,973
| -22% | -$368K |
|
741
Xencor
XNCR
$596M
| $1.29M | ﹤0.01% |
64,273
-31,242
| -33% | -$628K |
|
742
Arcus Biosciences
RCUS
$1.25B
| $1.29M | ﹤0.01% |
84,194
-11,598
| -12% | -$177K |
|
743
Travere Therapeutics
TVTX
$2.43B
| $1.28M | ﹤0.01% |
91,771
-90,521
| -50% | -$1.27M |
|
744
DocuSign
DOCU
$15.9B
| $1.28M | ﹤0.01% |
20,627
-11,894
| -37% | -$738K |
|
745
Charles River Laboratories
CRL
$7.54B
| $1.28M | ﹤0.01% |
6,500
-507
| -7% | -$99.9K |
|
746
Snap-on
SNA
$16.9B
| $1.28M | ﹤0.01% |
4,418
-116
| -3% | -$33.6K |
|
747
Bio-Techne
TECH
$7.93B
| $1.28M | ﹤0.01% |
15,984
-1,149
| -7% | -$91.8K |
|
748
Relay Therapeutics
RLAY
$700M
| $1.27M | ﹤0.01% |
180,030
-13,902
| -7% | -$98.4K |
|
749
Immunome
IMNM
$783M
| $1.27M | ﹤0.01% |
87,089
-28,956
| -25% | -$423K |
|
750
Caesars Entertainment
CZR
$5.33B
| $1.27M | ﹤0.01% |
30,417
-4,699
| -13% | -$196K |
|